{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:39Z","timestamp":1792783059290,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Athens","id":[{"id":"https:\/\/ror.org\/04gnjpq42","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-026-02250-9","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:55:53Z","timestamp":1771563353000},"page":"1871-1884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of ventricular tachycardia ablation versus antiarrhythmics in ischemic cardiomyopathy: a network meta-analysis"],"prefix":"10.1007","volume":"69","author":[{"given":"Konstantinos","family":"Pamporis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tsiachris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos-Konstantinos","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Kordalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Vlachos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Karakasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Botis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Theofilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini-Eleftheria","family":"Karanikola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"2250_CR1","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1093\/EURHEARTJ\/EHY556","volume":"39","author":"DD Berg","year":"2018","unstructured":"Berg DD, Wiviott SD, Braunwald E, Guo J, Im K, Kashani A, et al. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. Eur Heart J. 2018;39:3810\u201320. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHY556.","journal-title":"Eur Heart J"},{"key":"2250_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ahj.2009.10.019","volume":"159","author":"AS Adabag","year":"2010","unstructured":"Adabag AS, Peterson G, Apple FS, Titus J, King R, Luepker RV. Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation. Am Heart J. 2010;159:33\u20139. https:\/\/doi.org\/10.1016\/j.ahj.2009.10.019.","journal-title":"Am Heart J"},{"key":"2250_CR3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/J.HROO.2021.09.011","volume":"2","author":"U Sandhu","year":"2021","unstructured":"Sandhu U, Kovacs AH, Nazer B. Psychosocial symptoms of ventricular arrhythmias: integrating patient-reported outcomes into clinical care. Heart Rhythm O2. 2021;2:832\u20139. https:\/\/doi.org\/10.1016\/J.HROO.2021.09.011.","journal-title":"Heart Rhythm O2"},{"key":"2250_CR4","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/EURHEARTJ\/EHAC262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, De Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997\u20134126. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAC262.","journal-title":"Eur Heart J"},{"key":"2250_CR5","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1016\/J.HRTHM.2017.10.035","volume":"15","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15:e190-252. https:\/\/doi.org\/10.1016\/J.HRTHM.2017.10.035.","journal-title":"Heart Rhythm"},{"key":"2250_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/J.AHJ.2017.06.002","volume":"191","author":"DJ Friedman","year":"2017","unstructured":"Friedman DJ, Al-Khatib SM, Zeitler EP, Han JY, Bardy GH, Poole JE, et al. New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: a pooled analysis of 4 randomized controlled trials. Am Heart J. 2017;191:21\u20139. https:\/\/doi.org\/10.1016\/J.AHJ.2017.06.002.","journal-title":"Am Heart J"},{"key":"2250_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/J.HRTHM.2021.10.010","volume":"19","author":"MT Bennett","year":"2022","unstructured":"Bennett MT, Brown ML, Koehler J, Lexcen DR, Cheng A, Cheung JW. Trends in implantable cardioverter-defibrillator programming practices and its impact on therapies: insights from a North American Remote Monitoring Registry 2007-2018. Heart Rhythm. 2022;19:219\u201325. https:\/\/doi.org\/10.1016\/J.HRTHM.2021.10.010.","journal-title":"Heart Rhythm"},{"key":"2250_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.hroo.2021.08.005","volume":"2","author":"T Kleemann","year":"2021","unstructured":"Kleemann T, Lampropoulou E, Kouraki K, Strauss M, Fendt A, Zahn R. Management of implantable cardioverter-defibrillator patients with appropriate ICD shocks: a 3-step treatment concept. Heart Rhythm O2. 2021;2:537\u201340. https:\/\/doi.org\/10.1016\/j.hroo.2021.08.005.","journal-title":"Heart Rhythm O2"},{"key":"2250_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/JAMA.295.2.165","volume":"295","author":"SJ Connolly","year":"2006","unstructured":"Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of \u03b2-blockers, amiodarone plus \u03b2-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA. 2006;295:165\u201371. https:\/\/doi.org\/10.1001\/JAMA.295.2.165.","journal-title":"JAMA"},{"key":"2250_CR10","doi-asserted-by":"publisher","DOI":"10.15420\/AER.2023.07","author":"RK Reddy","year":"2023","unstructured":"Reddy RK, Howard JP, Ahmad Y, Shun-Shin MJ, Simader FA, Miyazawa AA, et al. Catheter ablation for ventricular tachycardia after MI: a reconstructed individual patient data meta-analysis of randomised controlled trials. Arrhythm Electrophysiol Rev. 2023. https:\/\/doi.org\/10.15420\/AER.2023.07.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2250_CR11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2409501\/SUPPL_FILE\/NEJMOA2409501_DATA-SHARING.PDF","author":"JL Sapp","year":"2024","unstructured":"Sapp JL, Tang ASL, Parkash R, Stevenson WG, Healey JS, Gula LJ, et al. Catheter ablation or antiarrhythmic drugs for ventricular tachycardia. N Engl J Med. 2024. https:\/\/doi.org\/10.1056\/NEJMOA2409501\/SUPPL_FILE\/NEJMOA2409501_DATA-SHARING.PDF.","journal-title":"N Engl J Med"},{"key":"2250_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/EUROPACE\/EUAF236","author":"P Raatikainen","year":"2025","unstructured":"Raatikainen P, M\u00e4kynen H, Hartikainen J, Urstad MJ, Konkola L, Sandgaard NCF, et al. Early substrate-based catheter ablation vs. antiarrhythmic drug therapy for ventricular tachyarrhythmias among patients with prior myocardial infarction: the MANTRA-VT randomized trial. Europace. 2025. https:\/\/doi.org\/10.1093\/EUROPACE\/EUAF236.","journal-title":"Europace"},{"key":"2250_CR13","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from www.training.cochrane.org\/handbook. n.d."},{"key":"2250_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/BMJ.N71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372. https:\/\/doi.org\/10.1136\/BMJ.N71.","journal-title":"BMJ"},{"key":"2250_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777\u201384. https:\/\/doi.org\/10.7326\/M14-2385.","journal-title":"Ann Intern Med"},{"key":"2250_CR16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/EUROPACE\/EUZ132","volume":"21","author":"EM Cronin","year":"2019","unstructured":"Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace. 2019;21:1143\u20134. https:\/\/doi.org\/10.1093\/EUROPACE\/EUZ132.","journal-title":"Europace"},{"key":"2250_CR17","doi-asserted-by":"publisher","unstructured":"Wallace BC, Small K, Brodley CE, Lau J, Trikalinos TA. Deploying an interactive machine learning system in an Evidence-based Practice Center: Abstrackr. IHI\u201912 - Proc 2nd ACM SIGHIT Int Heal Informatics Symp 2012;819\u201323. https:\/\/doi.org\/10.1145\/2110363.2110464.","DOI":"10.1145\/2110363.2110464"},{"key":"2250_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACC.2025.09.1595","author":"PB Nery","year":"2025","unstructured":"Nery PB, Wells GA, Tang ASL, Parkash R, Stevenson W, Healey JS, et al. Catheter ablation versus sotalol or amiodarone for ventricular tachycardia: a substudy of the VANISH2 trial. JACC. 2025. https:\/\/doi.org\/10.1016\/J.JACC.2025.09.1595.","journal-title":"JACC"},{"key":"2250_CR19","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/J.JACC.2022.01.050","volume":"79","author":"\u00c1 Arenal","year":"2022","unstructured":"Arenal \u00c1, \u00c1vila P, Jim\u00e9nez-Candil J, Tercedor L, Calvo D, Arribas F, et al. Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. J Am Coll Cardiol. 2022;79:1441\u201353. https:\/\/doi.org\/10.1016\/J.JACC.2022.01.050.","journal-title":"J Am Coll Cardiol"},{"key":"2250_CR20","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366. https:\/\/doi.org\/10.1136\/BMJ.L4898.","DOI":"10.1136\/BMJ.L4898"},{"key":"2250_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/JSS.V106.I02","volume":"106","author":"S Balduzzi","year":"2023","unstructured":"Balduzzi S, R\u00fccker G, Nikolakopoulou A, Papakonstantinou T, Salanti G, Efthimiou O, et al. Netmeta: an R package for network meta-analysis using frequentist methods. J Stat Softw. 2023;106:1\u201340. https:\/\/doi.org\/10.18637\/JSS.V106.I02.","journal-title":"J Stat Softw"},{"key":"2250_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/S11121-021-01289-6\/FIGURES\/2","volume":"23","author":"G Seitidis","year":"2022","unstructured":"Seitidis G, Nikolakopoulos S, Hennessy E, Tanner-Smith E, Mavridis D. Network meta-analysis techniques for synthesizing prevention science evidence. Prev Sci. 2022;23:415\u201324. https:\/\/doi.org\/10.1007\/S11121-021-01289-6\/FIGURES\/2.","journal-title":"Prev Sci"},{"key":"2250_CR23","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/SIM.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29:932\u201344. https:\/\/doi.org\/10.1002\/SIM.3767.","journal-title":"Stat Med"},{"key":"2250_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/JRSM.1044","volume":"3","author":"JPT Higgins","year":"2012","unstructured":"Higgins JPT, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods. 2012;3:98\u2013110. https:\/\/doi.org\/10.1002\/JRSM.1044.","journal-title":"Res Synth Methods"},{"key":"2250_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12874-015-0060-8\/TABLES\/4","volume":"15","author":"G R\u00fccker","year":"2015","unstructured":"R\u00fccker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15:1\u20139. https:\/\/doi.org\/10.1186\/S12874-015-0060-8\/TABLES\/4.","journal-title":"BMC Med Res Methodol"},{"key":"2250_CR26","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMOA1211107","volume":"367","author":"AJ Moss","year":"2012","unstructured":"Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275\u201383. https:\/\/doi.org\/10.1056\/NEJMOA1211107.","journal-title":"N Engl J Med"},{"key":"2250_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/JCE.12567","volume":"26","author":"SM Al-Khatib","year":"2015","unstructured":"Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, et al. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 2015;26:151\u20137. https:\/\/doi.org\/10.1111\/JCE.12567.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2250_CR28","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598\/SUPPL_FILE\/CIRC_CIRCULATIONAHA-2022-059598_SUPP1.PDF","volume":"145","author":"P Della Bella","year":"2022","unstructured":"Della Bella P, Baratto F, Vergara P, Bertocchi P, Santamaria M, Notarstefano P, et al. Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation. 2022;145:1829\u201338. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059598\/SUPPL_FILE\/CIRC_CIRCULATIONAHA-2022-059598_SUPP1.PDF.","journal-title":"Circulation"},{"key":"2250_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","volume":"375","author":"KH Kuck","year":"2010","unstructured":"Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacr\u00e9taz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(09)61755-4.","journal-title":"Lancet"},{"key":"2250_CR30","doi-asserted-by":"crossref","unstructured":"Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: Results from the multicenter randomized controlled SMS (Substrate . Circ Arrhythmia Electrophysiol 2017;10.","DOI":"10.1161\/CIRCEP.116.004422"},{"key":"2250_CR31","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMOA065457\/SUPPL_FILE\/NEJM_REDDY_2657SA1.PDF","volume":"357","author":"VY Reddy","year":"2007","unstructured":"Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657\u201365. https:\/\/doi.org\/10.1056\/NEJMOA065457\/SUPPL_FILE\/NEJM_REDDY_2657SA1.PDF.","journal-title":"N Engl J Med"},{"key":"2250_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMOA1513614\/SUPPL_FILE\/NEJMOA1513614_DISCLOSURES.PDF","volume":"375","author":"JL Sapp","year":"2016","unstructured":"Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin J-F, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111\u201321. https:\/\/doi.org\/10.1056\/NEJMOA1513614\/SUPPL_FILE\/NEJMOA1513614_DISCLOSURES.PDF.","journal-title":"N Engl J Med"},{"key":"2250_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/EUROPACE\/EUAE109","volume":"26","author":"D \u017di\u017eek","year":"2024","unstructured":"\u017di\u017eek D, Mrak M, Jan M, Me\u017enar AZ, Ivanovski M, \u017dlahti\u010d T, et al. Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion: the PREVENTIVE VT randomized multicentre trial. EP Eur. 2024;26:109. https:\/\/doi.org\/10.1093\/EUROPACE\/EUAE109.","journal-title":"EP Eur"},{"key":"2250_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0002-9149(98)00478-0","volume":"82","author":"K Seidl","year":"1998","unstructured":"Seidl K, Hauer B, Schwick NG, Zahn R, Senges J. Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter\/defibrillator. Am J Cardiol. 1998;82:744\u20138. https:\/\/doi.org\/10.1016\/S0002-9149(98)00478-0.","journal-title":"Am J Cardiol"},{"key":"2250_CR35","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM199906173402402\/ASSET\/A1FCA977-871C-4BED-A99C-7DEC75B39368\/ASSETS\/IMAGES\/LARGE\/NEJM199906173402402_T5.JPG","volume":"340","author":"A Pacifico","year":"1999","unstructured":"Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, et al. Prevention of implantable-defibrillator shocks by treatment with Sotalol. N Engl J Med. 1999;340:1855\u201362. https:\/\/doi.org\/10.1056\/NEJM199906173402402\/ASSET\/A1FCA977-871C-4BED-A99C-7DEC75B39368\/ASSETS\/IMAGES\/LARGE\/NEJM199906173402402_T5.JPG.","journal-title":"N Engl J Med"},{"key":"2250_CR36","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1046\/J.1460-9592.2002.01571.X","volume":"25","author":"K Kettering","year":"2002","unstructured":"Kettering K, Mewis C, D\u00f6rnberger V, Vonthein R, Bosch RF, K\u00fchlkamp V. Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2002;25:1571\u20136. https:\/\/doi.org\/10.1046\/J.1460-9592.2002.01571.X.","journal-title":"Pacing Clin Electrophysiol"},{"key":"2250_CR37","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/J.JACEP.2025.02.039;WEBSITE:WEBSITE:ACCPUBS;PAGEGROUP:STRING:PUBLICATION","volume":"11","author":"RK Reddy","year":"2025","unstructured":"Reddy RK, Samways JW, Howard JP, Ahmad Y, Shun-Shin MJ, Saleh K, et al. Catheter ablation for ventricular tachycardia after myocardial infarction: An updated meta-analysis of randomized controlled trials. JACC Clin Electrophysiol. 2025;11:1047\u201350. https:\/\/doi.org\/10.1016\/J.JACEP.2025.02.039;WEBSITE:WEBSITE:ACCPUBS;PAGEGROUP:STRING:PUBLICATION.","journal-title":"JACC Clin Electrophysiol"},{"key":"2250_CR38","doi-asserted-by":"publisher","unstructured":"Rashid A, Khan MF, Rashid J, RASHID A, Khan MF, Rashid J. A systematic review and meta-analysis of catheter ablation versus anti-arrhythmic drugs for treatment of ventricular arrhythmia. Cureus 2024;16. https:\/\/doi.org\/10.7759\/CUREUS.67649.","DOI":"10.7759\/CUREUS.67649"},{"key":"2250_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133597","author":"I Anagnostopoulos","year":"2025","unstructured":"Anagnostopoulos I, Vrachatis D, Kousta M, Giotaki S, Katsoulotou D, Karavasilis C, et al. Early catheter ablation versus conservative- only management in patients with electrical storm. Systematic review and meta- analysis. Int J Cardiol. 2025. https:\/\/doi.org\/10.1016\/j.ijcard.2025.133597.","journal-title":"Int J Cardiol"},{"key":"2250_CR40","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1161\/01.CIR.0000150390.04704.B7","volume":"110","author":"AJ Moss","year":"2004","unstructured":"Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760\u20135. https:\/\/doi.org\/10.1161\/01.CIR.0000150390.04704.B7.","journal-title":"Circulation"},{"key":"2250_CR41","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMOA071098","volume":"359","author":"JE Poole","year":"2008","unstructured":"Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009\u201317. https:\/\/doi.org\/10.1056\/NEJMOA071098.","journal-title":"N Engl J Med"},{"key":"2250_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/EUROPACE\/EUT289","volume":"16","author":"J Alexandre","year":"2014","unstructured":"Alexandre J, Saloux E, Lebon A, Dugu\u00e9 AE, Lemaitre A, Roule V, et al. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization. EP Eur. 2014;16:220\u20136. https:\/\/doi.org\/10.1093\/EUROPACE\/EUT289.","journal-title":"EP Eur"},{"key":"2250_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/VHRM.S6611","volume":"6","author":"H van Herendael","year":"2010","unstructured":"van Herendael H, Dorian P. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. Vasc Health Risk Manag. 2010;6:465. https:\/\/doi.org\/10.2147\/VHRM.S6611.","journal-title":"Vasc Health Risk Manag"},{"key":"2250_CR44","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1161\/CIRCULATIONAHA.122.060039","volume":"145","author":"R Tung","year":"2022","unstructured":"Tung R, Xue Y, Chen M, Jiang C, Shatz DY, Besser SA, et al. First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial. Circulation. 2022;145:1839\u201349. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060039.","journal-title":"Circulation"},{"issue":"1","key":"2250_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMOA1609758","volume":"377","author":"L Shen","year":"2017","unstructured":"Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, et al. Declining risk of sudden death in heart failure. N Engl J Med. 2017;377(1):41\u201351. https:\/\/doi.org\/10.1056\/NEJMOA1609758.","journal-title":"N Engl J Med"},{"issue":"13","key":"2250_CR46","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/CIRCULATIONAHA.112.000872","volume":"127","author":"P Della Bella","year":"2013","unstructured":"Della Bella P, Baratto F, Tsiachris D, Trevisi N, Vergara P, Bisceglia C, et al. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation. Circulation. 2013;127(13):1359\u201368. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.000872.","journal-title":"Circulation"},{"key":"2250_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.15420\/AER.2018.36.3","volume":"7","author":"D Muser","year":"2018","unstructured":"Muser D, Castro SA, Liang JJ, Santangeli P. Identifying risk and management of acute haemodynamic decompensation during catheter ablation of ventricular tachycardia. Arrhythm Electrophysiol Rev. 2018;7:282. https:\/\/doi.org\/10.15420\/AER.2018.36.3.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2250_CR48","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/S00392-021-01902-2","volume":"111","author":"S Mathew","year":"2022","unstructured":"Mathew S, Fink T, Feickert S, Inaba O, Hashiguchi N, Schl\u00fcter M, et al. Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score. Clin Res Cardiol. 2022;111:530\u201340. https:\/\/doi.org\/10.1007\/S00392-021-01902-2.","journal-title":"Clin Res Cardiol"},{"key":"2250_CR49","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.hrthm.2022.07.005","volume":"19","author":"N Prasitlumkum","year":"2022","unstructured":"Prasitlumkum N, Navaravong L, Desai A, Desai D, Cheungpasitporn W, Rattanawong P, et al. Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter-defibrillator: an updated systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2022;19:2054\u201361. https:\/\/doi.org\/10.1016\/j.hrthm.2022.07.005.","journal-title":"Heart Rhythm"},{"key":"2250_CR50","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCEP.114.001530","volume":"7","author":"P Peichl","year":"2014","unstructured":"Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J. Complications of catheter ablation of ventricular tachycardia a single-center experience. Circ Arrhythm Electrophysiol. 2014;7:684\u201390. https:\/\/doi.org\/10.1161\/CIRCEP.114.001530.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2250_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/S10840-021-00948-6","volume":"63","author":"WY Ding","year":"2022","unstructured":"Ding WY, Pearman CM, Bonnett L, Adlan A, Chin SH, Denham N, et al. Complication rates following ventricular tachycardia ablation in ischaemic and non-ischaemic cardiomyopathies: a systematic review. J Interv Card Electrophysiol. 2022;63:59\u201367. https:\/\/doi.org\/10.1007\/S10840-021-00948-6.","journal-title":"J Interv Card Electrophysiol"},{"key":"2250_CR52","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/J.JACEP.2025.01.020","volume":"11","author":"P Santangeli","year":"2025","unstructured":"Santangeli P, Hight N, Younis A, Liuba I, Lee J, Higuchi K, et al. A novel radiofrequency-assisted trans\u2013RAA perforation technique for pericardial CO2 insufflation to facilitate epicardial access. JACC Clin Electrophysiol. 2025;11:1145\u201355. https:\/\/doi.org\/10.1016\/J.JACEP.2025.01.020.","journal-title":"JACC Clin Electrophysiol"},{"key":"2250_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.hrthm.2017.09.005","volume":"15","author":"A Enriquez","year":"2018","unstructured":"Enriquez A, Liang J, Gentile J, Schaller RD, Supple GE, Frankel DS, et al. Outcomes of rescue cardiopulmonary support for periprocedural acute hemodynamic decompensation in patients undergoing catheter ablation of electrical storm. Heart Rhythm. 2018;15:75\u201380. https:\/\/doi.org\/10.1016\/j.hrthm.2017.09.005.","journal-title":"Heart Rhythm"},{"key":"2250_CR54","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.hrthm.2018.04.028","volume":"15","author":"D Muser","year":"2018","unstructured":"Muser D, Liang JJ, Castro SA, Hayashi T, Enriquez A, Troutman GS, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis. Heart Rhythm. 2018;15:1500\u20136. https:\/\/doi.org\/10.1016\/j.hrthm.2018.04.028.","journal-title":"Heart Rhythm"},{"key":"2250_CR55","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.jacep.2025.02.041","volume":"11","author":"A Bansal","year":"2025","unstructured":"Bansal A, Nandan A, Sroubek J, Lee J, Higuchi K, Hussein A, et al. Impact of hospital VT ablation volume on postprocedural complications: argument for selective referral to high-volume centers. JACC Clin Electrophysiol. 2025;11:1453\u201361. https:\/\/doi.org\/10.1016\/j.jacep.2025.02.041.","journal-title":"JACC Clin Electrophysiol"},{"key":"2250_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/EUROPACE\/EUAD225","author":"A Natale","year":"2023","unstructured":"Natale A, Zeppenfeld K, Della Bella P, Liu X, Sabbag A, Santangeli P, et al. Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look forward. Europace. 2023. https:\/\/doi.org\/10.1093\/EUROPACE\/EUAD225.","journal-title":"Europace"},{"key":"2250_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/EUROPACE\/EUX109","volume":"20","author":"DF Bricen\u00f5","year":"2018","unstructured":"Bricen\u00f5 DF, Romero J, Villablanca PA, London\u00f5 A, Diaz JC, Maraj I, et al. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. Europace. 2018;20:104\u201315. https:\/\/doi.org\/10.1093\/EUROPACE\/EUX109.","journal-title":"Europace"},{"key":"2250_CR58","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/S10840-022-01311-Z","volume":"66","author":"Q Marashly","year":"2023","unstructured":"Marashly Q, Najjar SN, Hahn J, Rector GJ, Khawaja M, Chelu MG. Innovations in ventricular tachycardia ablation. J Interv Card Electrophysiol. 2023;66:1499\u2013518. https:\/\/doi.org\/10.1007\/S10840-022-01311-Z.","journal-title":"J Interv Card Electrophysiol"},{"key":"2250_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.02.034","author":"EJ Ciaccio","year":"2025","unstructured":"Ciaccio EJ, Hsia HH, Saluja DS, Garan H, Coromilas J, Yarmohammadi H, et al. Ventricular tachycardia substrate mapping: what\u2019s been done and what needs to be done. Heart Rhythm. 2025. https:\/\/doi.org\/10.1016\/j.hrthm.2025.02.034.","journal-title":"Heart Rhythm"},{"key":"2250_CR60","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.hrthm.2024.06.014","volume":"22","author":"FM Cauti","year":"2025","unstructured":"Cauti FM, Martini N, Fioravanti F, Tanese N, Magnocavallo M, Rampa L, et al. Analysis of electrogram peak frequency during ventricular tachycardia ablation: insights into human tridimensional ventricular tachycardia circuits. Heart Rhythm. 2025;22:128\u201334. https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.014.","journal-title":"Heart Rhythm"},{"key":"2250_CR61","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/EURHEARTJ\/EHV316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Bloma N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793\u2013867. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHV316.","journal-title":"Eur Heart J"},{"key":"2250_CR62","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/EHJOPEN\/OEAF076","volume":"5","author":"A Maan","year":"2025","unstructured":"Maan A, Waseem M, Carter A, Vashishtha K, Dhanjal T, Koruth J, et al. Early vs. deferred catheter ablation of ventricular tachycardia in patients of ischaemic substrate: systematic review and meta-analysis of clinical outcomes. Eur Heart J Open. 2025;5:76. https:\/\/doi.org\/10.1093\/EHJOPEN\/OEAF076.","journal-title":"Eur Heart J Open"},{"key":"2250_CR63","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/EJHF.3512","volume":"27","author":"C Sohns","year":"2025","unstructured":"Sohns C, Fink T, Crijns HJGM, Costard-Jaeckle A, Marrouche NF, Sossalla S, et al. Preventive catheter ablation for ventricular arrhythmias in patients with end-stage heart failure referred for heart transplantation evaluation: rationale for and design of the CASTLE-VT trial. Eur J Heart Fail. 2025;27:690\u20136. https:\/\/doi.org\/10.1002\/EJHF.3512.","journal-title":"Eur J Heart Fail"},{"key":"2250_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/J.HRTHM.2020.11.015","volume":"18","author":"A Suzuki","year":"2021","unstructured":"Suzuki A, Lehmann HI, Wang S, Monahan KH, Parker KD, Rettmann ME, et al. Impact of myocardial fiber orientation on lesions created by a novel heated saline-enhanced radiofrequency needle-tip catheter: an MRI lesion validation study. Hear Rhythm. 2021;18:443\u201352. https:\/\/doi.org\/10.1016\/J.HRTHM.2020.11.015.","journal-title":"Hear Rhythm"},{"key":"2250_CR65","doi-asserted-by":"publisher","first-page":"191","DOI":"10.15420\/AER.2019.5.1","volume":"8","author":"T Nelson","year":"2019","unstructured":"Nelson T, Garg P, Clayton RH, Lee J. The role of cardiac MRI in the management of ventricular arrhythmias in ischaemic and non-ischaemic dilated cardiomyopathy. Arrhythmia Electrophysiol Rev. 2019;8:191\u2013201. https:\/\/doi.org\/10.15420\/AER.2019.5.1.","journal-title":"Arrhythmia Electrophysiol Rev"},{"key":"2250_CR66","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/J.JACEP.2023.08.008","volume":"9","author":"N Cedilnik","year":"2023","unstructured":"Cedilnik N, Pop M, Duchateau J, Sacher F, Ja\u00efs P, Cochet H, et al. Efficient patient-specific simulations of ventricular tachycardia based on computed tomography-defined wall thickness heterogeneity. JACC Clin Electrophysiol. 2023;9:2507\u201319. https:\/\/doi.org\/10.1016\/J.JACEP.2023.08.008.","journal-title":"JACC Clin Electrophysiol"},{"key":"2250_CR67","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jacep.2021.11.017","volume":"8","author":"BK Bauer","year":"2022","unstructured":"Bauer BK, Meier C, Bietenbeck M, Lange PS, Eckardt L, Yilmaz A. Cardiovascular magnetic resonance-guided radiofrequency ablation: where are we now? JACC Clin Electrophysiol. 2022;8:261\u201374. https:\/\/doi.org\/10.1016\/j.jacep.2021.11.017.","journal-title":"JACC Clin Electrophysiol"},{"key":"2250_CR68","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1161\/CIRCULATIONAHA.124.070526","volume":"151","author":"MC Waight","year":"2025","unstructured":"Waight MC, Prakosa A, Li AC, Bunce N, Marciniak A, Trayanova NA, et al. Personalized heart digital twins detect substrate abnormalities in scar-dependent ventricular tachycardia. Circulation. 2025;151:521\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070526.","journal-title":"Circulation"},{"key":"2250_CR69","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1093\/EURHEARTJ\/EHAB544","volume":"42","author":"VD Nagarajan","year":"2021","unstructured":"Nagarajan VD, Lee SL, Robertus JL, Nienaber CA, Trayanova NA, Ernst S. Artificial intelligence in the diagnosis and management of arrhythmias. Eur Heart J. 2021;42:3904\u201316. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAB544.","journal-title":"Eur Heart J"},{"key":"2250_CR70","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/CIRCRESAHA.120.317872\/ASSET\/972877A4-6F0C-4B5A-94DB-89EA4FFD4C4E\/ASSETS\/IMAGES\/LARGE\/CIRCRESAHA.120.317872.FIG06.JPG","volume":"128","author":"NA Trayanova","year":"2021","unstructured":"Trayanova NA, Popescu DM, Shade JK. Machine learning in arrhythmia and electrophysiology. Circ Res. 2021;128:544\u201366. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317872\/ASSET\/972877A4-6F0C-4B5A-94DB-89EA4FFD4C4E\/ASSETS\/IMAGES\/LARGE\/CIRCRESAHA.120.317872.FIG06.JPG.","journal-title":"Circ Res"},{"key":"2250_CR71","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jacep.2018.06.005","volume":"4","author":"FHM Wittkampf","year":"2018","unstructured":"Wittkampf FHM, van Es R, Neven K. Electroporation and its relevance for cardiac catheter ablation. JACC Clin Electrophysiol. 2018;4:977\u201386. https:\/\/doi.org\/10.1016\/j.jacep.2018.06.005.","journal-title":"JACC Clin Electrophysiol"},{"key":"2250_CR72","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/J.JACEP.2022.03.007","volume":"8","author":"SI Im","year":"2022","unstructured":"Im SI, Higuchi S, Lee A, Stillson C, Buck E, Morrow B, et al. Pulsed field ablation of left ventricular myocardium in a swine infarct model. JACC Clin Electrophysiol. 2022;8:722\u201331. https:\/\/doi.org\/10.1016\/J.JACEP.2022.03.007.","journal-title":"JACC Clin Electrophysiol"},{"key":"2250_CR73","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/EUROPACE\/EUZ341","volume":"22","author":"JS Koruth","year":"2020","unstructured":"Koruth JS, Kuroki K, Iwasawa J, Viswanathan R, Brose R, Buck ED, et al. Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation. Europace. 2020;22:434\u20139. https:\/\/doi.org\/10.1093\/EUROPACE\/EUZ341.","journal-title":"Europace"},{"key":"2250_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/S10840-022-01268-Z","author":"NY Tan","year":"2022","unstructured":"Tan NY, Ladas TP, Christopoulos G, Sugrue AM, van Zyl M, Ladejobi AO, et al. Ventricular nanosecond pulsed electric field delivery using active fixation leads: a proof-of-concept preclinical study. J Interv Card Electrophysiol. 2022. https:\/\/doi.org\/10.1007\/S10840-022-01268-Z.","journal-title":"J Interv Card Electrophysiol"},{"key":"2250_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/EUROPACE\/EUAF139","author":"F Sacher","year":"2025","unstructured":"Sacher F, Sarkozy A, P\u00fcrerfellner H, Steyer A, Lyne J, Coquard C, et al. Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the AFFERA Ventricular Arrhythmia Ablation Registry (AVAAR). Europace. 2025. https:\/\/doi.org\/10.1093\/EUROPACE\/EUAF139.","journal-title":"Europace"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02250-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:54:36Z","timestamp":1792572876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02250-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":75,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2250"],"URL":"https:\/\/doi.org\/10.1007\/s10840-026-02250-9","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval not applicable due to the meta-analytical nature of the study.","order":1,"name":"Ethics","label":"Ethical approval statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}